Non-hormonal treatment of hot flushes in breast cancer survivors: Gabapentin vs. vitamin e

N. Biglia, P. Sgandurra, E. Peano, D. Marenco, G. Moggio, V. Bounous, N. Tomasi Cont, R. Ponzone, P. Sismondi

Research output: Contribution to journalArticle

Abstract

Objectives To assess the efficacy and the tolerability of gabapentin 900 mgday compared to vitamin E for the control of vasomotor symptoms in 115 women with breast cancer. The secondary objective was to evaluate the effect of the treatments on the quality of sleep and other aspects of the quality of life. Methods A hot flush diary was completed daily; sleep quality and other menopausal symptoms were assessed with the Pittsburgh Sleep Quality Index PSQI, the Menopause Rating Scale MRS and the SF-36 Health Survey. Results The prescribed treatment with gabapentin was never started by 28.3 of the patients and was interrupted by 28 for side-effects dizziness and somnolence. Among the women allocated to vitamin E, 16.36 never started therapy and 34.78 dropped out because of inefficacy. Hot flush frequency and score decreased by 57.05 and 66.87, respectively p <0.05 in the gabapentin group. The effect of vitamin E was fairly small: hot flush frequency and score were reduced by 10.02 and 7.28, respectively p > 0.05. Gabapentin was also particularly effective in improving the quality of sleep PSQI score reduction: 21.33, p <0.05. Conclusion Gabapentin appears to be effective for the treatment of hot flushes with a favorable effect on quality of sleep. Vitamin E has only marginal effect on vasomotor symptoms.

Original languageEnglish
Pages (from-to)310-318
Number of pages9
JournalClimacteric
Volume12
Issue number4
DOIs
Publication statusPublished - 2009

Fingerprint

Vitamins
Survivors
Sleep
Breast Neoplasms
Vitamin E
Therapeutics
Dizziness
Menopause
Health Surveys
Quality of Life
gabapentin

Keywords

  • Breast cancer survivors
  • Gabapentin
  • Hot flushes
  • Menopausal symptoms
  • Vitamin E

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Biglia, N., Sgandurra, P., Peano, E., Marenco, D., Moggio, G., Bounous, V., ... Sismondi, P. (2009). Non-hormonal treatment of hot flushes in breast cancer survivors: Gabapentin vs. vitamin e. Climacteric, 12(4), 310-318. https://doi.org/10.1080/13697130902736921

Non-hormonal treatment of hot flushes in breast cancer survivors : Gabapentin vs. vitamin e. / Biglia, N.; Sgandurra, P.; Peano, E.; Marenco, D.; Moggio, G.; Bounous, V.; Tomasi Cont, N.; Ponzone, R.; Sismondi, P.

In: Climacteric, Vol. 12, No. 4, 2009, p. 310-318.

Research output: Contribution to journalArticle

Biglia, N, Sgandurra, P, Peano, E, Marenco, D, Moggio, G, Bounous, V, Tomasi Cont, N, Ponzone, R & Sismondi, P 2009, 'Non-hormonal treatment of hot flushes in breast cancer survivors: Gabapentin vs. vitamin e', Climacteric, vol. 12, no. 4, pp. 310-318. https://doi.org/10.1080/13697130902736921
Biglia, N. ; Sgandurra, P. ; Peano, E. ; Marenco, D. ; Moggio, G. ; Bounous, V. ; Tomasi Cont, N. ; Ponzone, R. ; Sismondi, P. / Non-hormonal treatment of hot flushes in breast cancer survivors : Gabapentin vs. vitamin e. In: Climacteric. 2009 ; Vol. 12, No. 4. pp. 310-318.
@article{79be621c234a45059f13ed2d61a666ae,
title = "Non-hormonal treatment of hot flushes in breast cancer survivors: Gabapentin vs. vitamin e",
abstract = "Objectives To assess the efficacy and the tolerability of gabapentin 900 mgday compared to vitamin E for the control of vasomotor symptoms in 115 women with breast cancer. The secondary objective was to evaluate the effect of the treatments on the quality of sleep and other aspects of the quality of life. Methods A hot flush diary was completed daily; sleep quality and other menopausal symptoms were assessed with the Pittsburgh Sleep Quality Index PSQI, the Menopause Rating Scale MRS and the SF-36 Health Survey. Results The prescribed treatment with gabapentin was never started by 28.3 of the patients and was interrupted by 28 for side-effects dizziness and somnolence. Among the women allocated to vitamin E, 16.36 never started therapy and 34.78 dropped out because of inefficacy. Hot flush frequency and score decreased by 57.05 and 66.87, respectively p <0.05 in the gabapentin group. The effect of vitamin E was fairly small: hot flush frequency and score were reduced by 10.02 and 7.28, respectively p > 0.05. Gabapentin was also particularly effective in improving the quality of sleep PSQI score reduction: 21.33, p <0.05. Conclusion Gabapentin appears to be effective for the treatment of hot flushes with a favorable effect on quality of sleep. Vitamin E has only marginal effect on vasomotor symptoms.",
keywords = "Breast cancer survivors, Gabapentin, Hot flushes, Menopausal symptoms, Vitamin E",
author = "N. Biglia and P. Sgandurra and E. Peano and D. Marenco and G. Moggio and V. Bounous and {Tomasi Cont}, N. and R. Ponzone and P. Sismondi",
year = "2009",
doi = "10.1080/13697130902736921",
language = "English",
volume = "12",
pages = "310--318",
journal = "Climacteric",
issn = "1369-7137",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Non-hormonal treatment of hot flushes in breast cancer survivors

T2 - Gabapentin vs. vitamin e

AU - Biglia, N.

AU - Sgandurra, P.

AU - Peano, E.

AU - Marenco, D.

AU - Moggio, G.

AU - Bounous, V.

AU - Tomasi Cont, N.

AU - Ponzone, R.

AU - Sismondi, P.

PY - 2009

Y1 - 2009

N2 - Objectives To assess the efficacy and the tolerability of gabapentin 900 mgday compared to vitamin E for the control of vasomotor symptoms in 115 women with breast cancer. The secondary objective was to evaluate the effect of the treatments on the quality of sleep and other aspects of the quality of life. Methods A hot flush diary was completed daily; sleep quality and other menopausal symptoms were assessed with the Pittsburgh Sleep Quality Index PSQI, the Menopause Rating Scale MRS and the SF-36 Health Survey. Results The prescribed treatment with gabapentin was never started by 28.3 of the patients and was interrupted by 28 for side-effects dizziness and somnolence. Among the women allocated to vitamin E, 16.36 never started therapy and 34.78 dropped out because of inefficacy. Hot flush frequency and score decreased by 57.05 and 66.87, respectively p <0.05 in the gabapentin group. The effect of vitamin E was fairly small: hot flush frequency and score were reduced by 10.02 and 7.28, respectively p > 0.05. Gabapentin was also particularly effective in improving the quality of sleep PSQI score reduction: 21.33, p <0.05. Conclusion Gabapentin appears to be effective for the treatment of hot flushes with a favorable effect on quality of sleep. Vitamin E has only marginal effect on vasomotor symptoms.

AB - Objectives To assess the efficacy and the tolerability of gabapentin 900 mgday compared to vitamin E for the control of vasomotor symptoms in 115 women with breast cancer. The secondary objective was to evaluate the effect of the treatments on the quality of sleep and other aspects of the quality of life. Methods A hot flush diary was completed daily; sleep quality and other menopausal symptoms were assessed with the Pittsburgh Sleep Quality Index PSQI, the Menopause Rating Scale MRS and the SF-36 Health Survey. Results The prescribed treatment with gabapentin was never started by 28.3 of the patients and was interrupted by 28 for side-effects dizziness and somnolence. Among the women allocated to vitamin E, 16.36 never started therapy and 34.78 dropped out because of inefficacy. Hot flush frequency and score decreased by 57.05 and 66.87, respectively p <0.05 in the gabapentin group. The effect of vitamin E was fairly small: hot flush frequency and score were reduced by 10.02 and 7.28, respectively p > 0.05. Gabapentin was also particularly effective in improving the quality of sleep PSQI score reduction: 21.33, p <0.05. Conclusion Gabapentin appears to be effective for the treatment of hot flushes with a favorable effect on quality of sleep. Vitamin E has only marginal effect on vasomotor symptoms.

KW - Breast cancer survivors

KW - Gabapentin

KW - Hot flushes

KW - Menopausal symptoms

KW - Vitamin E

UR - http://www.scopus.com/inward/record.url?scp=70350596476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350596476&partnerID=8YFLogxK

U2 - 10.1080/13697130902736921

DO - 10.1080/13697130902736921

M3 - Article

C2 - 19415540

AN - SCOPUS:70350596476

VL - 12

SP - 310

EP - 318

JO - Climacteric

JF - Climacteric

SN - 1369-7137

IS - 4

ER -